CClinicalTrials.gg
CompletedNCT02365116Updated Aug 15, 2017

Peer Mentorship to Reduce Suicide Risk Following Psychiatric Hospitalization

An interventional study of Peer mentorship and Enhanced Usual Care in Suicidal Ideation, sponsored by University of Michigan. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-08-15.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
79
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Every year in the United States about 1 million people make a suicide attempt and more than 38,000 die by suicide. The risk of suicide is highest among individuals with mental illness who have been hospitalized due to suicidal thoughts or behaviors, yet there are few interventions known to reduce suicide risk in this population. This study will develop and pilot test a peer mentorship intervention by which trained peer professionals will use their own personal experience with recovery from mental illness to instill hope and belongingness in high-risk patients and provide additional support to prevent future suicidal thoughts or behaviors.

The specific aims of the study are to: (1) develop a peer mentorship intervention to reduce suicide risk among patients psychiatrically hospitalized with suicidal ideation or following a suicide attempt; (2) Conduct a randomized controlled pilot study to assess the acceptability, feasibility, and fidelity of the peer mentorship intervention in preparation for a larger efficacy trial; and (3) an exploratory aim will be to measure potential mediators and moderators of intervention effectiveness in terms of belongingness, burdensomeness, and hopelessness according to the interpersonal theory of suicide.

02

Conditions studied

  • Suicidal Ideation

Keywords

  • Peer Mentorship
  • Psychiatric Hospitalization
  • Suicide Risk
03

In context

Suicide

701 studies on the registry are indexed under Suicide; 183 are open to participants now.

This study's enrollment of 79 is below the median of 104 across 560 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. are age 18 years or older
  2. have medical record documentation of suicidal ideation or suicide attempt at the time of admission
  3. are fluent in English

Exclusion criteria

Exclusion Criteria:

  1. substantially cognitively impaired (according to Mini-Cog)
  2. unable to provide voluntary, written, informed consent for any reason (including incompetency)
  3. determined by the patient's attending psychiatrist that due to the patient's psychiatric condition peer mentorship may be harmful to the patient or peer specialist (e.g., severe personality disorder, unstable paranoia)
  4. already receiving or intending to receive peer mentorship (including having a sponsor from Alcoholics Anonymous) or participate in group-based peer support on a biweekly or more frequent basis
  5. are receiving electroconvulsive therapy (ECT)
  6. are located more than 50 miles from any of the peer specialists
  7. are being discharged to a residential treatment facility
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
79 participants (actual)

Study arms

  • Experimental
    Peer Mentorship intervention

    A Peer Specialist will be making weekly follow-up contact with study participants in the community or by telephone for 3 months following hospital discharge. The content of the peer mentorship interactions will be based on the manual developed by the study team and will include components such as hope and belongingness.

    Behavioral: Peer mentorship

  • Active comparator
    Enhanced Usual Care

    Patients will continue to receive usual care which typically consists of referral to an outpatient psychiatrist. Participants will also receive a phone call within 24-72 hours from a member of the inpatient unit clinical staff to assess barriers to follow-up care and safety. The enhancement to usual care will occur at the 3 and 6 month follow-up assessments, where participants will be assessed to determine whether they require any additional referral information for follow-up care. If referral information is indicated, the patient will be provided a list of mental health treatment providers in their area.

    Behavioral: Enhanced Usual Care

Interventions

  • BehavioralPeer mentorship

    Patients who are working with a peer specialist will have their sessions audio taped and reviewed by research staff for training purposes and to ensure that peer specialists are following protocol.

  • BehavioralEnhanced Usual Care

    The enhancement to usual care will occur at the 3 and 6 month follow-up assessments, where participants will be assessed to determine whether they require any additional referral information for follow-up care. If referral information is indicated, the patient will be provided a list of mental health treatment providers in their area.

06

What researchers measure

Primary outcomes

  1. Intervention acceptability (median number of peer mentorship contacts at 3 months post-discharge is at least 4, as well as by satisfaction questionnaires.)

    Patients' willingness and satisfaction with participating in the intervention as a measure of intervention acceptability. Measured by at least 70% of participants in both study arms completing follow-up measures at 6 months, the median number of peer mentorship contacts at 3 months post-discharge is at least 4, as well as by satisfaction questionnaires.

    Time frame: 3 and 6 months post-baseline

  2. Intervention feasibility (Study team's ability to deliver the intervention)

    Study team's ability to deliver the intervention as a measure of feasibility. Measured by at least 50% of eligible patients choosing to enroll in the study, at least 80% of participants assigned to the peer mentorship arm meeting with a peer specialist prior to hospital discharge, at least 70% of participants in both study arms completing follow-up measures at 6 months, and the study meeting its enrollment goal of 60 patients in 12 months.

    Time frame: 3 and 6 months post-baseline

Secondary outcomes

  1. Current suicidal ideation (measured by the Beck Suicide Scale (BSS)

    Patient's current suicidal ideation as measured by the Beck Suicide Scale (BSS)

    Time frame: 3 and 6 months post-baseline

  2. Peak suicidal ideation (measured by the Columbia Suicide Severity Rating Scale (CSSR-S)

    Patient's peak suicidal ideation since the last visit as measured by the Columbia Suicide Severity Rating Scale (CSSR-S)

    Time frame: 3 and 6 months post-baseline

  3. Suicide attempts (measured by the Columbia Suicide Severity Rating Scale)

    Patient's suicide attempts since the last visit as measured by the Columbia Suicide Severity Rating Scale

    Time frame: 3 and 6 months post-baseline

07

Study locations

2 sites
  • University of Michigan Inpatient Psychiatry Unit
    Ann Arbor, Michigan 48109, United States
  • Henry Ford Kingswood Hospital
    Ferndale, Michigan 48220, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02365116
Lead sponsor
University of Michigan
Collaborators
National Institutes of Health (NIH)
Responsible party
Paul Pfeiffer (Assistant Professor of Psychiatry, University of Michigan) — Principal investigator
First posted
Feb 18, 2015
Start date
Aug 19, 2015
Primary completion
May 26, 2017
Completion
May 26, 2017
Last update
Aug 15, 2017

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion